Events

US-Russia Scientific Forum April 2011 Planning Meeting

April 25-26, 2011

On April 25-26, 2011, an organizational meeting took place in Moscow to prepare for The Forum planned for the fall of 2011.  This working meeting brought together U.S. and Russian government officials and researchers who discussed the development of the Forum Scientific Committee, determined working groups and assigned U.S. and Russian leads, determined and assigned tasks for Forum partners, and coordinated activities, budgets, and capabilities.
 
Russian participants in the planning meeting included senior officials of the Ministry of Health, the Russian Academy of Medical Sciences, the Russian Academy of Sciences, and heads and scientists from leading research institutions in Russia.
 
U.S. participants included the Director of the NIH Fogarty International Center, Director of NIH National Heart, Lung, and Blood Institute, President of the Institute of Medicine, American Chamber of Commerce (AmCham), and representatives from private companies.

U.S.-Russia Scientific Forum April, 2011 Planning Meeting Materials:
Agenda >>
List of Participants >>

U.S.-Russia Scientific Forum Presentations
Morning Presentations

Veronika Skvortsova, Deputy Minister, Ministry of Health & Social Development of the Russian Federation - Welcome Slides
Anatoly Grigoriev, Vice-President, Russian Academy of Sciences - Welcome Slides

Roger Glass, Director, Fogarty International Center, NIH - Welcome Slides
Valery Chereshnev, Chairman, State Duma Committee for Science and High Technology - Welcome Slides
Igor Goryanin, Executive Director, Biomedicine Cluster of Skolkovo - Presentation on Skolkovo

Afternoon Presentations
Alexander Baranov, Vice-President, Russian Academy of Medical Sciences - Human Development
Roger Glass, Director, Fogarty International Center, NIH - Human Development
Georgy Georgiev, Scientific Director, Institute of Gene Biology, Russian Academy of Sciences - Oncology
Ted Trimble, Head, Gynecologic Cancer Therapeutics & Quality of Cancer Care Therapeutics Clinical Investigative Branch, NIH - Oncology
Vitaly Zverev, Director, I. I. Mechnicov Research Institute of Vaccines & Sera - Infectious Disease
Robert Fontaine, Senior Advisor, Field Epidemiology Traning Program, CDC - Infectious Disease
Vsevolod Tkachuk, Dean, Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University - Cardiovascular Disease
Susan Shurin, Acting Director, National Heart, Lung, & Blood Institute, NIH - Cardiovascular Disease
Victor Tutelyan, Director, Institute of Nutrition, Russian Academy of Sciences - Healthy Lifestyles
Van Hubbard, Director, Division of Nutrition Research Coordination, NIH - Healthy Lifestyles
Gennady Sukhikh, Profesor & Acamedician, Russian Academy of Medical Sciences  - Clinical and Translational Research and Research Training

Private Company Presentations
Abbott Russia
Amway
Biomedical Technologies Cluster
Bionox
Bristol-Myers Squibb
GalenBio
Genzyme
Johnson & Johnson
Pfizer

Founding Private Partner

Eli Lilly logo

For additional information, please contact Ann Ashby, Deputy Executive Director, Foundation for the NIH, aashby [at] fnih [dot] org, 301-435-1641.
For press inquiries, please contact Kimberly O'Sullivan, Communications Manager, Foundation for the NIH, kosullivan [at] fnih [dot] org, 301-435-2613